Novartis hits pause on Fovista agreement Dive Brief: Novartis and Ophthotech Corp. have suspended big pieces of a licensing agreement for the latter company’s lead candidate until the drug can prove its effectiveness in late-stage… read more →
THE MACULAR DEGENERATION ASSOCIATION, INC. IS A REGISTERED 501(C)(3) NON-PROFIT CORPORATION. A COPY OF THE OFFICIAL REGISTRATION AND FINANCIAL INFORMATION MAY BE OBTAINED FROM THE DIVISION OF CONSUMER SERVICES BY CALLING TOLL-FREE WITHIN THE STATE (1-800-HELP-FLA) OR ON THE CONSUMER SERVICES WEBSITE WWW.800HELPFLA.COM . REGISTRATION DOES NOT IMPLY ENDORSEMENT, APPROVAL, OR RECOMMENDATION BY THE STATE.
The Macular Degeneration Association, Inc. is responsible for the content of this website. Its purpose is to provide useful information for persons with macular degeneration, their families, and the general public. This information is neither intended nor implied to be a substitute for professional medical advice relative to your specific medical condition or question. Always seek the advice of your physician or other health care provider for any questions you may have regarding your medical condition. Only your physician can provide specific diagnoses and treatments. The Macular Degeneration Association is recognized by the IRS as a 501 (c) (3) a tax exempt organization. The mission of the organization is to support research to help find a cure for macular degeneration and to improve the lives of all people affected by this disease. All content and works posted on this website are owned and copyrighted by the Macular Degeneration Association. All rights reserved. Copyright 2011 (c) Macular Degeneration Association. All rights reserved.